Atrayee Bhattacharya

Author

Dana-Farber Cancer Institute ORCID

Also Known As

Atrayee Bhattacharya, Atrayee Bhattarchya

126

Publications

629

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Harvard University Roswell Park Comprehensive Cancer Center Keio University The University of Osaka

About

Atrayee Bhattacharya is an author at Dana-Farber Cancer Institute specializing in cancer research, tumor biology, and cancer genetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	40
2	Cell Biology	2	2	40
3	Cancer Genetics	2	2	40
4	Immunology	1	1	22
5	Cancer Cell Biology	1	1	22

Atrayee Bhattacharya

Publications

521

Citations

H-Index

Page 1

	Year	Citations
MUC1-C Activates the BAF (mSWI/SNF) Complex in Prostate Cancer Stem Cells Masayuki Hagiwara, Yota Yasumizu, Nami Yamashita, Cancer Research	2020	78
MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer Nami Yamashita, Mark D. Long, Atsushi Fushimi, Journal for ImmunoTherapy of Cancer	2021	73
MUC1-C activates the PBAF chromatin remodeling complex in integrating redox balance with progression of human prostate cancer stem cells Masayuki Hagiwara, Atsushi Fushimi, Nami Yamashita, Oncogene	2021	68
MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC Naoki Haratake, Hiroki Ozawa, Yoshihiro Morimoto, Journal of Thoracic Oncology	2023	37
The calcium channel proteins ORAI3 and STIM1 mediate TGF-β induced<i>Snai1</i>expression Atrayee Bhattacharya, Janani Kumar, Kole Hermanson, Oncotarget	2018	32
MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer Nami Yamashita, Yoshihiro Morimoto, Atsushi Fushimi, Molecular Cancer Research	2022	32
MUC1-C is a master regulator of MICA/B NKG2D ligand and exosome secretion in human cancer cells Yoshihiro Morimoto, Nami Yamashita, Tatsuaki Daimon, Journal for ImmunoTherapy of Cancer	2023	25
MUC1-C intersects chronic inflammation with epigenetic reprogramming by regulating the set1a compass complex in cancer progression Atrayee Bhattacharya, Atsushi Fushimi, Keyi Wang, Communications Biology	2023	23
Targeting MUC1-C Suppresses Chronic Activation of Cytosolic Nucleotide Receptors and STING in Triple-Negative Breast Cancer Nami Yamashita, Atsushi Fushimi, Yoshihiro Morimoto, Cancers Breast OncologyImmunologyCytosolic Nucleotide ReceptorsCancer BiologyIntrinsic Expression	2022	22
Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment Yoshihiro Morimoto, Atsushi Fushimi, Nami Yamashita, Oncogene	2022	18

Page 1